← Association for Accessible Medicines
FDANonrulemakingFDA-2011-D-0605

Scientific Considerations in Demonstrating Biosimilarity to a Reference Product

RIN
—
Last modified
Jan 8, 2026
Comment window
closed 189d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jan 21, 2026 and Jan 21, 2026. 1 other organizations filed here. The comment window closed 189d ago.

What Association for Accessible Medicines filed (1)

Jan 21, 2026· Comment from Association for Accessible Medicines / Biosimilars Council· FDA-2011-D-0605-0081

Comments from the Biosimilars Council to Docket No. FDA-2011-D-0605: Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (1)

See everyone who commented →